Cargando…

Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553867/
http://dx.doi.org/10.1007/s40278-021-04680-3
_version_ 1784591665958223872
collection PubMed
description
format Online
Article
Text
id pubmed-8553867
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85538672021-10-29 Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report Reactions Weekly Case Report Springer International Publishing 2021-10-30 2021 /pmc/articles/PMC8553867/ http://dx.doi.org/10.1007/s40278-021-04680-3 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title_full Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title_fullStr Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title_full_unstemmed Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title_short Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
title_sort itolizumab/sodium chloride: second degree heart block secondary to infusion related hypersensitivity reaction: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553867/
http://dx.doi.org/10.1007/s40278-021-04680-3